ERBB2 and breast neoplasm: To investigate the combinational effect of aspirin and Compound C on HER-2-positive breast tumor growth in vivo, we established a xenograft model in female mice by injecting them with stably overexpressing SKBR-3-luciferase-positive cells; mice were then treated with aspirin with or without Compound C for 30 days.